Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §103 only | 1 (12%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.7% |
| MONTANARI, DAVID A | 1 | 64.8% | +49.2% |
| LEITH, NANCY J | 1 | 74.7% | +43.8% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 58.6% | +39.6% |
| GRABER, JAMES J | 1 | 45.9% | +57.0% |
| WESTON, ALYSSA G | 1 | 60.0% | +51.3% |
| RYAN, DOUGLAS CHARLES | 1 | 40.3% | +50.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18537754 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | VIVLEMORE, TRACY ANN | 30d overdue |
| 16093334 | GRNA FUSION MOLECULES, GENE EDITING SYSTEMS, AND METHODS OF USE THEREOF | RYAN, DOUGLAS CHARLES | 40d |
| 16899302 | CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING | WESTON, ALYSSA G | — |
| 16098845 | GENETICALLY ENGINEERED CELLS AND METHODS OF MAKING THE SAME | VIVLEMORE, TRACY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17433975 | CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP) | SULLIVAN, STEPHANIE LAUREN | 114d overdue |
| 17430382 | MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY | GRABER, JAMES J | 56d overdue |
| 17533007 | EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES | LEITH, NANCY J | 28d |
| 16093334 | GRNA FUSION MOLECULES, GENE EDITING SYSTEMS, AND METHODS OF USE THEREOF | RYAN, DOUGLAS CHARLES | 40d |
| 17836165 | OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS | MONTANARI, DAVID A | — |
| 16899302 | CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1635 | 2 |
| 1632 | 1 |
| 1636 | 1 |
| 1631 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18537754 | SELECTION BY ESSENTIAL-GENE KNOCK-IN | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Final Rejection | 30d overdue | Pending | Dec 12, 2023 |
| 17836165 | OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS | MONTANARI, DAVID A | 1632 | §112 | Non-Final OA | — | Pending | Jun 09, 2022 |
| 17533007 | EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES | LEITH, NANCY J | 1636 | §103Other | Final Rejection | 28d | Pending | Nov 22, 2021 |
| 17433975 | CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP) | SULLIVAN, STEPHANIE LAUREN | 1635 | §103DP | Final Rejection | 114d overdue | Pending | Aug 25, 2021 |
| 17430382 | MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY | GRABER, JAMES J | 1631 | §102§103§112DP | Final Rejection | 56d overdue | Pending | Aug 12, 2021 |
| 16899302 | CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING | WESTON, ALYSSA G | 1633 | §102§103§112 | Non-Final OA | — | Pending | Jun 11, 2020 |
| 16098845 | GENETICALLY ENGINEERED CELLS AND METHODS OF MAKING THE SAME | VIVLEMORE, TRACY ANN | 1638 | §101§103§112 | Final Rejection | — | Pending | Nov 02, 2018 |
| 16093334 | GRNA FUSION MOLECULES, GENE EDITING SYSTEMS, AND METHODS OF USE THEREOF | RYAN, DOUGLAS CHARLES | 1635 | §101§103§112 | Non-Final OA | 40d | Pending | Oct 12, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial